Swiss pharmaceuticals giant Novartis has decided to halt a clinical trial of hydroxychloroquine as a treatment for COVID-19, citing problems in recruiting enough patients for the study of the controversial drug. “Novartis has made the decision to stop and ...
from Google Alert - health https://ift.tt/2YWSIkW
via IFTTT
0 comments:
Post a Comment